Nigeria Healthcare Investment

The Nigeria Sovereign Investment Authority (NSIA) through its wholly owned subsidiary, Healthcare Development and Investment Company (NHDIC), is undertaking a phased expansion of its healthcare program. The expansion aims to establish several diagnostic centers and interventional cardiology suites across Nigeria which will predominantly be domiciled in existing tertiary healthcare institutions. The scope of the expansion includes:

• Twenty-two new modern medical diagnostic centers: which will provide modern radiology and pathology services – including six cardiac catheterization labs spread over the six geo-political zones of the country.
• Phase one will consist of ten diagnostic centers and two cardiac catheterization labs embedded in existing tertiary hospitals. 
• Phase two will consist of twelve diagnostic centers and four cardiac catheterization labs embedded in existing tertiary hospitals. The procurement would be done either as an outright purchase or a six-year lease. 

The NSIA has sent out Request for Proposal (RFP) to medical OEMs and vendors for equipment supply, installation, maintenance, and personnel training for these projects. The NSIA plans to build a world-class hospital in the country’s capital, Abuja, as part of efforts to strengthen the country’s underdeveloped healthcare system.

With the disruption in global supply chains for pharmaceuticals and vaccines during the Covid-19 pandemic, NSIA sees opportunities in these areas and will invest in local manufacturing of pharmaceutical products and vaccines for communicable diseases. The NSIA was established in 2011 to manage Nigeria’s sovereign wealth fund financed by surplus oil income. This sovereign wealth fund was founded for the purpose of managing and investing these funds on behalf of the government of Nigeria. At the end of December 2021, the fund had $2.56 billion in assets under management.

For more information, contact Commercial Specialist Chamberlain Eke at chamberlain.eke@trade.gov.